RA
Rise Advisors Portfolio holdings
AUM
$252M
1-Year Return
13.63%
This Quarter Return
-1.6%
1 Year Return
+13.63%
3 Year Return
+48.05%
5 Year Return
–
10 Year Return
–
AUM
$226M
AUM Growth
+$18.4M
(+8.9%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
10.52%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
1,582
New
463
Increased
381
Reduced
582
Closed
80
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
+$4.8M |
| 2 |
Vanguard Value ETF
VTV
|
+$4.32M |
| 3 |
FT Vest Laddered Moderate Buffer ETF
BUFZ
|
+$4.12M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$3.63M |
| 5 |
Dimensional US Targeted Value ETF
DFAT
|
+$3.41M |
Top Sells
| 1 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$3.74M |
| 2 |
PayPal
PYPL
|
+$2.55M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$528K |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$203K |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$178K |
Sector Composition
| 1 | Technology | 7.6% |
| 2 | Financials | 5.8% |
| 3 | Consumer Discretionary | 3.39% |
| 4 | Healthcare | 2.99% |
| 5 | Industrials | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Q2 Holdings
QTWO
$5.17B
| $11.1K | ﹤0.01% |
+139
| New | +$11.1K |
|
902
Donaldson
DCI
$9.51B
| $11.1K | ﹤0.01% |
165
-121
| -42% | -$8.14K |
|
903
American States Water
AWR
$2.83B
| $11K | ﹤0.01% |
+140
| New | +$11K |
|
904
Quest Diagnostics
DGX
$20.5B
| $11K | ﹤0.01% |
+65
| New | +$11K |
|
905
Northern Trust
NTRS
$24.7B
| $11K | ﹤0.01% |
+111
| New | +$11K |
|
906
Littelfuse
LFUS
$6.72B
| $10.9K | ﹤0.01% |
56
-68
| -55% | -$13.3K |
|
907
Albemarle
ALB
$8.83B
| $10.9K | ﹤0.01% |
152
+41
| +37% | +$2.95K |
|
908
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $10.9K | ﹤0.01% |
+273
| New | +$10.9K |
|
909
Prestige Consumer Healthcare
PBH
$3.2B
| $10.9K | ﹤0.01% |
127
-28
| -18% | -$2.41K |
|
910
Grand Canyon Education
LOPE
$5.88B
| $10.9K | ﹤0.01% |
63
-37
| -37% | -$6.4K |
|
911
Akamai
AKAM
$11.4B
| $10.9K | ﹤0.01% |
135
+11
| +9% | +$886 |
|
912
First Industrial Realty Trust
FR
$6.97B
| $10.9K | ﹤0.01% |
201
-162
| -45% | -$8.75K |
|
913
Lumentum
LITE
$11.5B
| $10.8K | ﹤0.01% |
174
-115
| -40% | -$7.17K |
|
914
Protagonist Therapeutics
PTGX
$3.71B
| $10.8K | ﹤0.01% |
+224
| New | +$10.8K |
|
915
Incyte
INCY
$16.8B
| $10.8K | ﹤0.01% |
178
-132
| -43% | -$7.99K |
|
916
Kilroy Realty
KRC
$5.08B
| $10.8K | ﹤0.01% |
329
-158
| -32% | -$5.18K |
|
917
Treehouse Foods
THS
$906M
| $10.8K | ﹤0.01% |
397
+49
| +14% | +$1.33K |
|
918
SPS Commerce
SPSC
$4.26B
| $10.8K | ﹤0.01% |
81
| – | – |
|
919
Wendy's
WEN
$1.88B
| $10.7K | ﹤0.01% |
734
-201
| -21% | -$2.94K |
|
920
Moderna
MRNA
$9.88B
| $10.7K | ﹤0.01% |
378
+73
| +24% | +$2.07K |
|
921
Neogen
NEOG
$1.25B
| $10.7K | ﹤0.01% |
1,233
+157
| +15% | +$1.36K |
|
922
BridgeBio Pharma
BBIO
$10.1B
| $10.7K | ﹤0.01% |
+309
| New | +$10.7K |
|
923
ADMA Biologics
ADMA
$3.84B
| $10.7K | ﹤0.01% |
+538
| New | +$10.7K |
|
924
Globe Life
GL
$11.5B
| $10.7K | ﹤0.01% |
+81
| New | +$10.7K |
|
925
Equity Residential
EQR
$25.5B
| $10.7K | ﹤0.01% |
+149
| New | +$10.7K |
|